High-Margin Research Peptide e-commerce Business with Strong Customer Retention

Industry Overview

Operates within the international research peptide market, specialising in premium research-grade products with an emphasis on quality assurance, transparency and reliability.

Location

Australia, United Kingdom, United States (international e-commerce operations).

Business Description

A direct-to-consumer e-commerce business offering independently tested research peptides manufactured in Hong Kong. Global fulfilment is supported by distribution depots in Australia, the UK and the US, with lean, documented operations.

Financial Summary

The business generates approximately USD 1.10 million in annual revenue, achieving an 84% profit margin within the research peptide sector.

• TTM Revenue: USD 1.10 million
• TTM Earnings: USD 916,546
• Earnings Margin: 84%

Investment Rationale

• Approximately 85% repeat purchase rate demonstrating strong customer loyalty.
• Average order value of approximately USD 280.
• Third-party product testing supporting quality and transparency.
• Established organic acquisition through SEO and email marketing, without reliance on paid advertising.
• Growth opportunities through paid acquisition, subscriptions and product expansion.

Customer Overview

Loyal international customer base comprising researchers, biohackers and performance-focused consumers, supported by consistent product quality and transparent testing.

Transaction Information

Opportunity to acquire a 50% equity stake through a direct share purchase from existing shareholders. Includes inventory and access to established operations. Full details available under NDA.